AzTrials
AzTrials

Schizophrenia PatientsNCT07148609

Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.

A study testing Video game-facilitated group activity in people with Schizophrenia Patients, run by TsaoTun Psychiatric Center, Department of Health, Taiwan at 1 site in Taiwan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia. Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Schizophrenia Patients
What is being tested?
Video game-facilitated group activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteTaiwan
Study dates
3 May 2025to 31 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals aged between >18 and <65 years with a principal diagnosis of schizophrenia, as defined by the International Classification of Diseases (ICD-10) codes F20.0-F20.9 which was diagnosed according to DSM-5-TR criteria.
  • Possessing a valid Catastrophic Illness Certificate for schizophrenia and being continuously hospitalized for more than six months.
  • Being able to read Chinese and communicate effectively in either Mandarin or Taiwanese.
  • Being able to comprehend the purpose of the study and to provide written informed consent after the study has been explained by the researchers.

Who cannot join

  • Individuals exhibiting unstable psychiatric or consciousness conditions, or those unable to comply with video game-based instruction and operation.
  • Individuals with a history of ocular diseases, severe cardiovascular disorders, epilepsy, or brain injuries; or those who have experienced acute cardiovascular or cerebrovascular events, bone fractures, undergone hip or knee joint replacement, or present with lower limb balance impairments or structural injuries-such as amputations, post-lumbar surgery status, or acute ankle sprains-rendering participation unsuitable within the past six months.
  • Concurrent participation in other research studies during the study period, where the intervention may potentially influence the primary or secondary outcomes of this study.
  • Individuals who are legally declared under guardianship.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Tsao-Tun Psychiatric Center, Ministry of Health and Welfare

    Nantou City, Taiwan, 54249

Other trials in Taiwan

About this study

Official title: Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients: A Randomized Controlled Parallel-group Pilot Trial.

The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia.

The main questions it aims to answer are:

Read more
  • Does video game-facilitated group activity enhance the quality of life as measured by a standardized scale (WHOQOL) in patients with schizophrenia hospitalized in a psychiatric hospital?
  • Can video game-facilitated group activity promote social function as measured by a specific scale (PSP) in patients with schizophrenia hospitalized in a psychiatric hospital?

Researchers will compare video game-facilitated group activity to regular occupational therapy to see if the intervention is beneficial to patients with chronic schizophrenia.

Participants will:

  • Attend to video game-facilitated group activity or regular occupational therapy three times a week for 12 weeks.
  • Receive assessments upon and after the 12-week intervention, and another 12 weeks after the intervention ends.
Being tested
Video game-facilitated group activity
Keywords
Video game, Schizophrenia, Social function, Quality of life
Medical subject headings
Schizophrenia, Social Adjustment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video game-facilitated group activityBehavioural

    The intervention is a 12-week group activity program for each participant in the intervention group, and the program consists of three 50-minute video game facilitated group activity sessions per week. Participants in the intervention group will engage in those group activity session which will be mediated by the game of Super Mario Party on Nintendo Switch.

Study groups in NCT07148609
Study groupRoleWhat they receive
Interventional armActive comparatorNot described
Receives: Behavioral: Video game-facilitated group activity
Controlled armNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The changes of quality of life

    The changes of quality of life will be assessed by the World Health Organization Quality of Life-BREF (WHOQOL-BREF).

    Measured: The outcome will be assessed at baseline, week 12, and week 24.

  2. The changes of social function.

    The changes of social function will be evaluated by the Personal and Social Performance Scale (PSP).

    Measured: The outcome will be assessed at baseline, week 12, and week 24

Secondary outcomes (4)
  1. The changes of cerebral blood flow.

    The changes in cerebral blood be measured by Near-Infrared Spectroscopy (NIRS).

    Measured: The outcome will be assessed at baseline and week 12.

  2. The change of cognitive function.

    The Montreal Cognitive Assessment (MoCA) will be used to evaluate changes in cognitive function.

    Measured: The outcome will be assessed at baseline and week 12.

  3. The change of psychiatric symptoms.

    The Brief Psychiatric Rating Scale (BPRS) will be used to assess changes in positive and negative psychiatric symptoms.

    Measured: The outcome will be assessed at baseline and week 12.

  4. The change of physical fitness

    Physical fitness assessments will be conducted to measure changes in participants' physical fitness levels, including cardiopulmonary endurance, the strength and flexibility of upper and lower limbs, as well as dynamic and static balance.

    • The cardiopulmonary endurance would be measured by 6-minute walk test and march-in-place test.
    • The upper limbs strength will be measured by arm curl test and hand grip strength test.
    • The lower limbs strength will be measured by 30-second chair stand test.
    • The upper limbs flexibility will be measured by back scratch test.
    • The lower limbs flexibility will be measured by chair sit-and-reach test.
    • The dynamic balance test will be measured by chair stand and obstacle walk test.
    • The static balance test will be measured by one-leg stand test with eyes open.

    Measured: The outcome will be assessed at baseline and week 12.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2025
  2. Study start3 May 2025
  3. Primary completion31 Mar 2026 (estimated)
  4. Study completion31 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07148609
Sponsor's protocol ID
TTPC-114015
Status last verified
Aug 2025
First submitted
23 Aug 2025
Last updated
29 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Video game-facilitated group activity in people with Schizophrenia Patients, run by TsaoTun Psychiatric Center, Department of Health, Taiwan at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The changes of quality of life (time frame: The outcome will be assessed at baseline, week 12, and week 24.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in